tomeko

Angelman syndrome due to imprinting defect in 15q11-q13

Just diagnosed with Angelman syndrome due to imprinting defect in 15q11-q13?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Angelman syndrome due to imprinting defect in 15q11-q13, look for clinical trials, and connect with others living with it — all in one place.

Open the full Angelman syndrome due to imprinting defect in 15q11-q13 hub →

Overview

Angelman syndrome due to imprinting defect in 15q11-q13 is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Angelman syndrome due to imprinting defect in 15q11-q13 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:411515 · ICD-10 Q93.5 · GARD 0021733

Find care for Angelman syndrome due to imprinting defect in 15q11-q13

Authoritative references for Angelman syndrome due to imprinting defect in 15q11-q13

Common questions

I was just diagnosed with Angelman syndrome due to imprinting defect in 15q11-q13 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Angelman syndrome due to imprinting defect in 15q11-q13, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Angelman syndrome due to imprinting defect in 15q11-q13?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Angelman syndrome due to imprinting defect in 15q11-q13, filtered to your area.

Are there clinical trials for Angelman syndrome due to imprinting defect in 15q11-q13?

Tomeko shows live, recruiting studies for Angelman syndrome due to imprinting defect in 15q11-q13 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com